LGT Financial Advisors’s Gilead Sciences GILD Stock Holding History

LGT Financial Advisors’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-21	Closed	-$2.93K	–	236
2026 Q1	$2.93K	Hold	21	–	–	0.02%	222
2025 Q4	$2.58K	Hold	21	–	–	0.02%	230
2025 Q3	$2.33K	Hold	21	–	–	0.01%	336
2025 Q2	$2.35K	Buy	+21	New	+$2.23K	0.01%	350
2024 Q1	–	Sell	-55	Closed	-$4.46K	–	812
2023 Q4	$4.46K	Sell	55 -23	-29%	-$1.79K	0.01%	655
2023 Q3	$5.84K	Buy	+78	New	+$6K	0.01%	582

Other funds holding GILD

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

LGT Financial Advisors's GILD Position: Q2 2026 in Review

LGT Financial Advisors sold out of Gilead Sciences (GILD) in Q2 2026, closing a stake of 21 shares — an estimated $2.93K sold.

LGT Financial Advisors first reported a position in GILD in Q3 2023 and held it in 6 quarters. The position peaked at $5.84K in Q3 2023. 1,245 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

LGT Financial Advisors reported no remaining Gilead Sciences position as of Q2 2026 after selling out during the quarter.
LGT Financial Advisors sold 21 Gilead Sciences shares in Q2 2026, an estimated $2.93K.
LGT Financial Advisors first reported a position in Gilead Sciences in Q3 2023 and held it in 6 quarters.
LGT Financial Advisors's Gilead Sciences position peaked at $5.84K in Q3 2023.
1,245 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on LGT Financial Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.